Augmedix Statistics
Share Statistics
Augmedix has 49.43M
shares outstanding. The number of shares has increased by 0.94%
in one year.
| Shares Outstanding | 49.43M |
| Shares Change (YoY) | 0.94% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 67.45% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 1,416 |
| FTD / Avg. Volume | 0.18% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -13.41 and the forward
PE ratio is null.
Augmedix's PEG ratio is
0.35.
| PE Ratio | -13.41 |
| Forward PE | n/a |
| PS Ratio | 5.73 |
| Forward PS | n/a |
| PB Ratio | 11.02 |
| P/FCF Ratio | -13.86 |
| PEG Ratio | 0.35 |
Financial Ratio HistoryEnterprise Valuation
Augmedix has an Enterprise Value (EV) of 236.59M.
| EV / Sales | 5.27 |
| EV / EBITDA | -13.38 |
| EV / EBIT | -15.32 |
| EV / FCF | -12.76 |
Financial Position
The company has a current ratio of 2.41,
with a Debt / Equity ratio of 0.93.
| Current Ratio | 2.41 |
| Quick Ratio | 2.41 |
| Debt / Equity | 0.93 |
| Debt / EBITDA | -1.46 |
| Debt / FCF | -1.39 |
| Interest Coverage | -8.34 |
Financial Efficiency
Return on Equity is -82.2% and Return on Invested Capital is -41.94%.
| Return on Equity | -82.2% |
| Return on Assets | -28.74% |
| Return on Invested Capital | -41.94% |
| Revenue Per Employee | $31,367.13 |
| Profits Per Employee | $-13,406.29 |
| Employee Count | 1,430 |
| Asset Turnover | 0.67 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 145K |
| Effective Tax Rate | -0.76% |
Stock Price Statistics
The stock price has increased by -17.54% in the
last 52 weeks. The beta is -0.19, so Augmedix's
price volatility has been lower than the market average.
| Beta | -0.19 |
| 52-Week Price Change | -17.54% |
| 50-Day Moving Average | 2.3 |
| 200-Day Moving Average | 2.97 |
| Relative Strength Index (RSI) | 74.06 |
| Average Volume (20 Days) | 808,771 |
Income Statement
In the last 12 months, Augmedix had revenue of 44.85M
and earned -19.17M
in profits. Earnings per share was -0.44.
| Revenue | 44.85M |
| Gross Profit | 21.53M |
| Operating Income | -18.78M |
| Net Income | -19.17M |
| EBITDA | -17.68M |
| EBIT | -16.77M |
| Earnings Per Share (EPS) | -0.44 |
Full Income StatementBalance Sheet
The company has 46.34M in cash and 25.85M in
debt, giving a net cash position of 20.5M.
| Cash & Cash Equivalents | 46.34M |
| Total Debt | 25.85M |
| Net Cash | 20.5M |
| Retained Earnings | -144.96M |
| Total Assets | 53.67M |
| Working Capital | 15.93M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -15.44M
and capital expenditures -3.1M, giving a free cash flow of -18.55M.
| Operating Cash Flow | -15.44M |
| Capital Expenditures | -3.1M |
| Free Cash Flow | -18.55M |
| FCF Per Share | -0.42 |
Full Cash Flow StatementMargins
Gross margin is 47.99%, with operating and profit margins of -41.87% and -42.74%.
| Gross Margin | 47.99% |
| Operating Margin | -41.87% |
| Pretax Margin | -42.42% |
| Profit Margin | -42.74% |
| EBITDA Margin | -39.42% |
| EBIT Margin | -41.87% |
| FCF Margin | -41.35% |
